Position in TAK
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$456,536
+$108,755 QoQ
Shares Held
24,651
+10.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Parallel Advisors, LLC holds $7,470,447 across 34 Drug Manufacturers - Specialty & Generic names. TAK ranks #4 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
27,846 | $3,291,675 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
88,173 | $1,221,196 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,056 | $626,186 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
24,651 | $456,536 | |
| 5 | VTRS |
Viatris Inc
|
26,426 | $357,015 | |
| 6 | HLN |
Haleon plc
|
30,272 | $303,022 | |
| 7 | ESPR |
Esperion Therapeutics, Inc.
|
96,254 | $263,735 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
1,776 | $233,970 |
All Filings in TAK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $456,536 | 24,651 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $347,781 | 22,308 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $348,973 | 23,837 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $376,265 | 24,338 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $295,214 | 19,853 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $216,791 | 16,374 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $133,625 | 9,397 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $72,140 | 5,575 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $89,854 | 6,469 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $76,772 | 5,380 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $110,765 | 7,160 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $103,811 | 6,608 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $83,636 | 5,075 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $53,851 | 3,452 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $147,287 | 11,356 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $150,452 | 10,716 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $144,231 | 10,072 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $98,885 | 7,255 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $96,854 | 5,913 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $76,340 | 4,536 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $86,881 | 4,758 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $69,232 | 3,804 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $78,513 | 4,401 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $80,936 | 4,514 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $38,025 | 2,505 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||